Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Dendritic Cell Vaccine in Metastatic Breast Cancer
NCT00197925Phase 2Terminated
- Sponsor
- Herlev Hospital
- Start
- Sep 2004
- Modality
- Prophylactic Vaccines, Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of autologous dendritic cell vaccine in breast cancer, sponsored by Herlev Hospital. Started Sep 2004; status: terminated.
02
Drugs
autologous dendritic cell vaccine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00197925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00197925.